Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $141.6600 (1.01%) ($141.6600 - $141.6600) on Tue. Feb. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.81% (three month average) | RSI | 37 | Latest Price | $141.6600(1.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -2.5% a day on average for past five trading days. | Weekly Trend | LGND declines -12.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(58%) IWM(54%) IWC(53%) XBI(53%) | Factors Impacting LGND price | LGND will decline at least -2.405% in a week (0% probabilities). VIXM(-28%) UUP(-18%) VXX(-17%) UNG(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.405% (StdDev 4.81%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $173.36 | 5 Day Moving Average | $143.74(-1.45%) | 10 Day Moving Average | $164.14(-13.7%) | 20 Day Moving Average | $173.36(-18.29%) | To recent high | -34.4% | To recent low | 69.7% | Market Cap | $2.277b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |